<!DOCTYPE html>
<html lang="en-us">
<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.2.0">
  <meta name="generator" content="Hugo 0.54.0" />

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Geert Litjens">

  
  
  
    
  
  <meta name="description" content="The key to MR lymphography is suppression of T2* MR signal in normal lymph nodes, while retaining high signal in metastatic nodes. Our objective is to quantitatively compare the ability of ferumoxtran-10 and ferumoxytol to suppress the MR signal in normal pelvic lymph nodes. In 2010, a set of consecutive patients who underwent intravenous MR Lymphography (MRL) were included. Signal suppression in normal lymph nodes in T2*-weighted images due to uptake of USPIO (Ultra-Small Superparamagnetic Particles of Iron Oxide) was quantified. Signal suppression by two USPIO contrast agents, ferumoxtran-10 and ferumoxytol was compared using Wilcoxon&#39;s signed rank test. Forty-four patients were included, of which all 44 had a ferumoxtran-10 MRL and 4 had additionally a ferumoxytol MRL. A total of 684 lymph nodes were identified in the images, of which 174 had been diagnosed as metastatic. USPIO-induced signal suppression in normal lymph nodes was significantly stronger in ferumoxtran-10 MRL than in ferumoxytol MRL (p &lt; 0.005). T2* signal suppression in normal pelvic lymph nodes is significantly stronger with ferumoxtran-10 than with ferumoxytol, which may affect diagnostic accuracy.">

  
  <link rel="alternate" hreflang="en-us" href="https://%3cUSERNAME%3e.github.io/publication/deba-16-a/">

  


  

  

  

  

  

  

  
  
  
  <meta name="theme-color" content="hsl(339, 90%, 68%)">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.1.3/css/bootstrap.min.css" integrity="sha256-eSi1q2PG6J7g7ib17yAaWMcrr5GrtohYChqibrV7PBE=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.6.0/css/all.css" integrity="sha384-aOkxzJ5uQz7WBObEZcHvV5JvRW3TUc2rNPA7pe3AwnsUohiw1Vj2Rgx2KSOkF5+h" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    

    

    

  

  
  
  <link rel="stylesheet" href="//fonts.googleapis.com/css?family=Montserrat:400,700|Roboto:400,400italic,700|Roboto+Mono">
  

  <link rel="stylesheet" href="/styles.css">
  
    
    
    
    
      
    
    
    
    <link rel="stylesheet" href="/css/academic.7704f968b5354870b409458e901eab0c.css">
  

  
  
  

  
  <link rel="alternate" href="https://%3cUSERNAME%3e.github.io/index.xml" type="application/rss+xml" title="Geert Litjens">
  <link rel="feed" href="https://%3cUSERNAME%3e.github.io/index.xml" type="application/rss+xml" title="Geert Litjens">
  

  <link rel="manifest" href="/site.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="https://%3cUSERNAME%3e.github.io/publication/deba-16-a/">

  
  
  
  
    
    
  
  <meta property="twitter:card" content="summary">
  
  <meta property="og:site_name" content="Geert Litjens">
  <meta property="og:url" content="https://&lt;USERNAME&gt;.github.io/publication/deba-16-a/">
  <meta property="og:title" content="Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol. | Geert Litjens">
  <meta property="og:description" content="The key to MR lymphography is suppression of T2* MR signal in normal lymph nodes, while retaining high signal in metastatic nodes. Our objective is to quantitatively compare the ability of ferumoxtran-10 and ferumoxytol to suppress the MR signal in normal pelvic lymph nodes. In 2010, a set of consecutive patients who underwent intravenous MR Lymphography (MRL) were included. Signal suppression in normal lymph nodes in T2*-weighted images due to uptake of USPIO (Ultra-Small Superparamagnetic Particles of Iron Oxide) was quantified. Signal suppression by two USPIO contrast agents, ferumoxtran-10 and ferumoxytol was compared using Wilcoxon&#39;s signed rank test. Forty-four patients were included, of which all 44 had a ferumoxtran-10 MRL and 4 had additionally a ferumoxytol MRL. A total of 684 lymph nodes were identified in the images, of which 174 had been diagnosed as metastatic. USPIO-induced signal suppression in normal lymph nodes was significantly stronger in ferumoxtran-10 MRL than in ferumoxytol MRL (p &lt; 0.005). T2* signal suppression in normal pelvic lymph nodes is significantly stronger with ferumoxtran-10 than with ferumoxytol, which may affect diagnostic accuracy."><meta property="og:image" content="https://.github.io/img/icon-192.png">
  <meta property="og:locale" content="en-us">
  
  <meta property="article:published_time" content="2016-10-01T00:00:00&#43;02:00">
  
  <meta property="article:modified_time" content="2016-10-01T00:00:00&#43;02:00">
  

  

  

  <title>Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol. | Geert Litjens</title>

</head>
<body id="top" data-spy="scroll" data-target="#TableOfContents" data-offset="71" class="dark">
  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/">Geert Litjens</a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav ml-auto">
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#posts">
            
            <span>Posts</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#projects">
            
            <span>Projects</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#media">
            
            <span>Media</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#presentations">
            
            <span>Presentations</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#publications">
            
            <span>Publications</span>
            
          </a>
        </li>

        
        

        

        
        
        
          
        

        <li class="nav-item">
          <a class="nav-link" href="/#about">
            
            <span>About</span>
            
          </a>
        </li>

        
        

        

        
        
        

        <li class="nav-item">
          <a class="nav-link" href="/cv">
            
            <span>CV</span>
            
          </a>
        </li>

        
        

      

        

        

        

        

      </ul>

    </div>
  </div>
</nav>

<div class="pub" itemscope itemtype="http://schema.org/CreativeWork">

  












  

  
  
  
<div class="article-container pt-3">
  <h1 itemprop="name">Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol.</h1>

  

  
    



<meta content="2016-10-01 00:00:00 &#43;0200 CEST" itemprop="datePublished">
<meta content="2016-10-01 00:00:00 &#43;0200 CEST" itemprop="dateModified">

<div class="article-metadata">

  
  
  
  
  <div>
    



  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      <a href="/authors/o.-debats/">O. Debats</a></span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      <a href="/authors/a.-fortuin/">A. Fortuin</a></span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      <a href="/authors/h.-meijer/">H. Meijer</a></span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      <a href="/authors/t.-hambrock/">T. Hambrock</a></span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      <a href="/authors/g.-litjens/">G. Litjens</a></span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      <a href="/authors/j.-barentsz/">J. Barentsz</a></span></span>, 
  <span itemscope itemprop="author" itemtype="http://schema.org/Person">
      <span itemprop="name">
        

      
      
      <a href="/authors/h.-huisman/">H. Huisman</a></span></span>
  



  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    <time>October, 2016</time>
  </span>
  

  

  

  
  

  

  
    

  

</div>

    







  






  



<div class="btn-links mb-3">
  
  








  



<a class="btn btn-outline-primary my-1 mr-1" href="/publication/deba-16-a/deba-16-a.pdf" target="_blank" rel="noopener">
  PDF
</a>



<button type="button" class="btn btn-outline-primary my-1 mr-1 js-cite-modal"
        data-filename="/publication/deba-16-a/deba-16-a.bib">
  Cite
</button>













<a class="btn btn-outline-primary my-1 mr-1" href="https://doi.org/10.7717/peerj.2471" target="_blank" rel="noopener">
  DOI
</a>



</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract" itemprop="text">The key to MR lymphography is suppression of T2* MR signal in normal lymph nodes, while retaining high signal in metastatic nodes. Our objective is to quantitatively compare the ability of ferumoxtran-10 and ferumoxytol to suppress the MR signal in normal pelvic lymph nodes. In 2010, a set of consecutive patients who underwent intravenous MR Lymphography (MRL) were included. Signal suppression in normal lymph nodes in T2<em>-weighted images due to uptake of USPIO (Ultra-Small Superparamagnetic Particles of Iron Oxide) was quantified. Signal suppression by two USPIO contrast agents, ferumoxtran-10 and ferumoxytol was compared using Wilcoxon&rsquo;s signed rank test. Forty-four patients were included, of which all 44 had a ferumoxtran-10 MRL and 4 had additionally a ferumoxytol MRL. A total of 684 lymph nodes were identified in the images, of which 174 had been diagnosed as metastatic. USPIO-induced signal suppression in normal lymph nodes was significantly stronger in ferumoxtran-10 MRL than in ferumoxytol MRL (p &lt; 0.005). T2</em> signal suppression in normal pelvic lymph nodes is significantly stronger with ferumoxtran-10 than with ferumoxytol, which may affect diagnostic accuracy.</p>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            

            
            
            <a href="/publication/#3">
              Journal article
            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9"><em>PeerJ</em></div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    


<div class="article-tags">
  
  <a class="badge badge-light" href="/tags/lymph-node-metastases-mr-lymphography-prostate-cancer-uspio-contrast-agents/">Lymph node metastases; MR lymphography; Prostate cancer; USPIO contrast agents</a>
  
</div>



    






  
  
    
  
  








  </div>
</div>


<div class="article-container article-widget">
  <div class="post-nav">
  
  <div class="post-nav-item">
    <div class="meta-nav">Next</div>
    <a href="https://%3cUSERNAME%3e.github.io/publication/laba-17/" rel="next">MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences: implications for immunotherapy</a>
  </div>
  
  
  <div class="post-nav-item">
    <div class="meta-nav">Previous</div>
    <a href="https://%3cUSERNAME%3e.github.io/publication/ehte-16-a/" rel="prev">Automated Detection of DCIS in Whole-Slide H&amp;E Stained Breast Histopathology Images</a>
  </div>
  
</div>

</div>


<div class="container">
  <footer class="site-footer">
  

  <p class="powered-by">
    &copy; 2019 &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" id="back_to_top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

</div>


<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

    

    
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.3.1/jquery.min.js" integrity="sha512-+NqPlbbtM1QqiK8ZAo4Yrj2c4lNQoGv8P79DPtKzj++l5jnN39rHA/xsqn8zE9l0uSoxaCdrOgFs6yjyfbBxSg==" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/4.1.3/js/bootstrap.min.js" integrity="sha256-VsEqElsCHSGmnmHXGQzvoWjWwoznFSZc6hs7ARLRacQ=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      

      
      
    

    
    

    
    
    

    
    

    

    
    

    

    
    

    
    

    
    
    
    
    
    
    
      
    
    
    
    
    <script src="/js/academic.min.01d176c6a39ffaaa2714dda311205d60.js"></script>

  </body>
</html>

